Sorting out the roles of PPAR alpha in energy metabolism and vascular homeostasis

The Journal of Clinical Investigation
Philippe LefebvreBart Staels

Abstract

PPARalpha is a nuclear receptor that regulates liver and skeletal muscle lipid metabolism as well as glucose homeostasis. Acting as a molecular sensor of endogenous fatty acids (FAs) and their derivatives, this ligand-activated transcription factor regulates the expression of genes encoding enzymes and transport proteins controlling lipid homeostasis, thereby stimulating FA oxidation and improving lipoprotein metabolism. PPARalpha also exerts pleiotropic antiinflammatory and antiproliferative effects and prevents the proatherogenic effects of cholesterol accumulation in macrophages by stimulating cholesterol efflux. Cellular and animal models of PPARalpha help explain the clinical actions of fibrates, synthetic PPARalpha agonists used to treat dyslipidemia and reduce cardiovascular disease and its complications in patients with the metabolic syndrome. Although these preclinical studies cannot predict all of the effects of PPARalpha in humans, recent findings have revealed potential adverse effects of PPARalpha action, underlining the need for further study. This Review will focus on the mechanisms of action of PPARalpha in metabolic diseases and their associated vascular pathologies.

References

Jan 1, 1984·British Journal of Clinical Pharmacology·K MurakamiY Shigeta
Nov 7, 1996·Nature·P R DevchandW Wahli
Apr 29, 1997·Proceedings of the National Academy of Sciences of the United States of America·B M FormanR M Evans
Apr 29, 1997·Proceedings of the National Academy of Sciences of the United States of America·S A KliewerJ M Lehmann
Jun 8, 1999·The Journal of Clinical Investigation·S KerstenW Wahli
May 29, 2000·The Journal of Biological Chemistry·M Guerre-MilloB Staels
Jun 23, 2000·The Journal of Clinical Investigation·P M BargerD P Kelly
Jul 6, 2000·Circulation·UNKNOWN Bezafibrate Infarction Prevention (BIP) study

❮ Previous
Next ❯

Citations

Dec 16, 2006·Current Atherosclerosis Reports·Jennifer G Robinson
Dec 4, 2010·Archives of Toxicology·Mohammad Monir TawfeeqKunitoshi Mitsumori
Jun 10, 2010·Mammalian Genome : Official Journal of the International Mammalian Genome Society·Nam-Kuk KimChang-Soo Lee
May 16, 2013·Cancer Metastasis Reviews·Ming ShiNing Guo
Mar 12, 2010·Reviews in Endocrine & Metabolic Disorders·Fredrick L Dunn
Aug 12, 2006·Current Atherosclerosis Reports·Thomas Dayspring, Gregory Pokrywka
Feb 5, 2008·Current Atherosclerosis Reports·Jose M Ordovas
Dec 17, 2008·Current Atherosclerosis Reports·Peter P TothGregory S Pokrywka
Apr 29, 2010·Current Osteoporosis Reports·Beata Lecka-Czernik
Sep 1, 2007·Hepatology International·David van der Poorten, Jacob George
Nov 14, 2012·Journal of Agricultural and Food Chemistry·Tsuyoshi GotoTeruo Kawada
Dec 24, 2009·International Journal of Obesity : Journal of the International Association for the Study of Obesity·C TouriñoR Maldonado
Jul 17, 2008·Nature Clinical Practice. Cardiovascular Medicine·Bart StaelsAlberto Zambon
Aug 23, 2011·Nature Medicine·Guenter HaemmerleRudolf Zechner
Jun 23, 2010·Nature Reviews. Endocrinology·Anne HiukkaMarja-Riitta Taskinen
Apr 28, 2010·Nature Reviews. Nephrology·Xiaoxin X WangMoshe Levi
Apr 9, 2008·Oncogene·D N GrossM J Birnbaum
Nov 23, 2012·Biologie aujourd'hui·Vincent BérézowskiRoméo Cecchelli
Jan 18, 2008·Proceedings of the National Academy of Sciences of the United States of America·Dipak PanigrahyMark W Kieran
May 7, 2009·Proceedings of the National Academy of Sciences of the United States of America·Patrizia CampolongoDaniele Piomelli
Sep 11, 2009·The Journal of Biological Chemistry·David PatsourisJerrold M Olefsky
May 1, 2010·The Journal of Biological Chemistry·Ryosuke DoiNorio Ishida
Mar 1, 2012·The Journal of Biological Chemistry·Sabeera BonalaRavi Kambadur
Jun 5, 2012·The Journal of Biological Chemistry·Holly A CyphertF Bradley Hillgartner
Jan 5, 2007·Journal of Medicinal Food·Shylesh BhaskaranSampath Parthasarathy
Jun 27, 2008·Briefings in Functional Genomics & Proteomics·Leroy HoodJohn D Aitchison
Dec 9, 2010·Journal of Biochemistry·Fumiko IwamotoYukio Fujiki
Jan 30, 2010·Nucleic Acids Research·David L M van der MeerSander Kersten
May 7, 2009·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Peter KloverLothar Hennighausen
Sep 12, 2009·Behavioural Pharmacology·Amany Ali Eissa AhmedNouf Mohammed Al-Rasheed
Oct 30, 2008·Current Opinion in Lipidology·Mohammed Mahmood Hussain, Ahmed Bakillah

❮ Previous
Next ❯

Methods Mentioned

BETA
acetylation
ubiquitination

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.